Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
160003-66-7
|
| gptkbp:drugClass |
gptkb:nootropic
neuroprotective agent |
| gptkbp:hasInChIKey |
QZKQKQJQJQJQJQ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C21H23ClN2O2
|
| gptkbp:hasSMILES |
COC1=CC=C(C=C1)N2CCN(CC2=O)C3=CC=C(C=C3)Cl
|
| gptkbp:investigatedBy |
gptkb:Alzheimer's_disease
|
| gptkbp:IUPACName |
1-(4-chlorophenyl)-4-(4-methoxyphenyl)piperazine-2-one
|
| gptkbp:PubChem_CID |
9795382
|
| gptkbp:synonym |
1-(4-chlorophenyl)-4-(4-methoxyphenyl)piperazin-2-one
OCL-1017 |
| gptkbp:bfsParent |
gptkb:Melotte_162
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
OCL 1017
|